期刊
NATURE REVIEWS CANCER
卷 18, 期 12, 页码 744-757出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41568-018-0074-8
关键词
-
类别
资金
- German Research Foundation (DFG)
- European Research Council (ERC) (Mechanisms of Evasive Resistance in Cancer (MERiC))
- Louis Jeantet Foundation
- Swiss National Science Foundation
- SystemsX.CH
Oncogenic signalling and metabolic alterations are interrelated in cancer cells. mTOR, which is frequently activated in cancer, controls cell growth and metabolism. mTOR signalling regulates amino acid, glucose, nucleotide, fatty acid and lipid metabolism. Conversely, metabolic inputs, such as amino acids, activate mTOR. In this Review, we discuss how mTOR signalling rewires cancer cell metabolism and delineate how changes in metabolism, in turn, sustain mTOR signalling and tumorigenicity. Several drugs are being developed to perturb cancer cell metabolism. However, their efficacy as stand-alone therapies, similar to mTOR inhibitors, is limited. Here, we discuss how the interdependence of mTOR signalling and metabolism can be exploited for cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据